Journal of Oncology / 2016 / Article / Fig 4

Clinical Study

Does the Degree of Hepatocellular Carcinoma Tumor Necrosis following Transarterial Chemoembolization Impact Patient Survival?

Figure 4

(a) Crude, unadjusted post-TACE survival as a function of mRECIST category. (b) Adjusted post-TACE survival as a function of mRECIST category.
(a)
(b)